BIOMARIN PHARMACEUTICAL INC Quarterly Depreciation in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Biomarin Pharmaceutical Inc quarterly/annual Depreciation history and growth rate from Q2 2010 to Q3 2024.
  • Biomarin Pharmaceutical Inc Depreciation for the quarter ending September 30, 2024 was $10.9M, a 10.1% increase year-over-year.
  • Biomarin Pharmaceutical Inc Depreciation for the twelve months ending September 30, 2024 was $45.7M, a 19.3% increase year-over-year.
  • Biomarin Pharmaceutical Inc annual Depreciation for 2023 was $40.3M, a 4.4% increase from 2022.
  • Biomarin Pharmaceutical Inc annual Depreciation for 2022 was $38.6M, a 16.3% decline from 2021.
  • Biomarin Pharmaceutical Inc annual Depreciation for 2021 was $46.1M, a 7.21% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $45.7M $10.9M +$1M +10.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-31
Q2 2024 $44.7M $11.5M +$2.1M +22.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-05
Q1 2024 $42.6M $12.6M +$2.3M +22.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-26
Q4 2023 $40.3M $10.7M +$2M +23% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $38.3M $9.9M +$1.2M +13.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-31
Q2 2023 $37.1M $9.4M -$100K -1.05% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-05
Q1 2023 $37.2M $10.3M -$1.4M -12% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-26
Q4 2022 $38.6M $8.7M -$1.7M -16.3% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $40.3M $8.7M -$2.7M -23.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $43M $9.5M -$2.3M -19.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $45.3M $11.7M -$800K -6.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-28
Q4 2021 $46.1M $10.4M +$9.72M +1429% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $36.4M $11.4M +$300K +2.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-28
Q2 2021 $36.1M $11.8M +$2.1M +21.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $34M $12.5M -$9.02M -41.9% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q4 2020 $43M $680K +$16M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $27M $11.1M -$13.1M -54.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-10-29
Q2 2020 $40.1M $9.7M -$11.8M -54.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-30
Q1 2020 $51.9M $21.5M +$120K +0.56% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q4 2019 $51.8M -$15.4M -$39M -165% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $90.8M $24.2M -$2.36M -8.88% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $93.2M $21.5M +$1.43M +7.11% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $91.8M $21.4M +$1.4M +7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-01
Q4 2018 $90.4M $23.7M +$2.68M +12.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $87.7M $26.6M +$7.2M +37.1% Jul 1, 2018 Sep 30, 2018 10-Q/A 2019-11-04
Q2 2018 $80.5M $20.1M +$2.2M +12.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $78.3M $20M +$2.5M +14.3% Jan 1, 2018 Mar 31, 2018 10-Q 2019-04-29
Q4 2017 $75.8M $21M +$3.9M +22.8% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $71.9M $19.4M -$3.8M -16.4% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-26
Q2 2017 $75.7M $17.9M +$700K +4.07% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $75M $17.5M +$1.8M +11.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-04-27
Q4 2016 $73.2M $17.1M +$3.5M +25.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $69.7M $23.2M +$10.5M +82.7% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $59.2M $17.2M +$4.9M +39.8% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-02
Q1 2016 $54.3M $15.7M +$4.2M +36.5% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $50.1M $13.6M +$500K +3.82% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-26
Q3 2015 $49.6M $12.7M +$1.5M +13.4% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-03
Q2 2015 $48.1M $12.3M +$1.9M +18.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $46.2M $11.5M +$1.9M +19.8% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q4 2014 $44.3M $13.1M +$3.9M +42.4% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 $40.4M $11.2M +$2M +21.7% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 $38.4M $10.4M +$1M +10.6% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-05
Q1 2014 $37.4M $9.6M +$900K +10.3% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-05
Q4 2013 $36.5M $9.2M $0 0% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $36.5M $9.2M +$300K +3.37% Jul 1, 2013 Sep 30, 2013 10-Q 2014-10-28
Q2 2013 $36.2M $9.4M +$1M +11.9% Apr 1, 2013 Jun 30, 2013 10-Q 2014-07-31
Q1 2013 $35.2M $8.7M +$300K +3.57% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q4 2012 $34.9M $9.2M +$200K +2.22% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-02
Q3 2012 $34.7M $8.9M +$800K +9.88% Jul 1, 2012 Sep 30, 2012 10-Q 2013-10-28
Q2 2012 $33.9M $8.4M +$1M +13.5% Apr 1, 2012 Jun 30, 2012 10-Q 2013-07-29
Q1 2012 $32.9M $8.4M +$1M +13.5% Jan 1, 2012 Mar 31, 2012 10-Q 2013-04-29
Q4 2011 $31.9M $9M Oct 1, 2011 Dec 31, 2011 10-K 2014-02-26
Q3 2011 $8.1M +$1.8M +28.6% Jul 1, 2011 Sep 30, 2011 10-Q 2012-10-29
Q2 2011 $7.4M +$2.2M +42.3% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-02
Q1 2011 $7.4M Jan 1, 2011 Mar 31, 2011 10-Q 2012-04-30
Q3 2010 $6.3M Jul 1, 2010 Sep 30, 2010 10-Q 2011-10-31
Q2 2010 $5.2M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.